Skip to main content
. Author manuscript; available in PMC: 2021 Sep 3.
Published in final edited form as: Brain Pathol. 2021 Jan 28;31(4):e12918. doi: 10.1111/bpa.12918

Figure 9.

Figure 9.

Clinical outcomes for patients with intracranial mesenchymal tumors with FET-CREB fusion based on mucin content of the stroma. A, B. Kaplan-Meier plot of overall survival (A) and progression-free survival (B) for the 20 patients from this study stratified by mucin-rich versus mucin-poor stroma.